Cargando…
Atypical Amniotic Fluid Embolism Managed with a Novel Therapeutic Regimen
Amniotic fluid embolism (AFE) is the second leading cause of maternal mortality in the USA with an incidence of 1 : 15,200 births. The case fatality rate and perinatal mortality associated with AFE are 13–30% and 9–44%, respectively. This rare but devastating complication can be difficult to diagnos...
Autores principales: | Rezai, Shadi, Hughes, Alexander C., Larsen, Tracy B., Fuller, Paul N., Henderson, Cassandra E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753013/ https://www.ncbi.nlm.nih.gov/pubmed/29430313 http://dx.doi.org/10.1155/2017/8458375 |
Ejemplares similares
-
Atypical presentation of amniotic fluid embolism in liver and colon
por: Zizzo, Maurizio, et al.
Publicado: (2019) -
Amniotic fluid embolism
por: Rudra, A., et al.
Publicado: (2009) -
Amniotic fluid embolism
por: Thongrong, Cattleya, et al.
Publicado: (2013) -
Amniotic fluid embolism
por: Kaur, Kiranpreet, et al.
Publicado: (2016) -
Atropine, Ondansetron, and Ketorolac: Supplemental Management of Amniotic Fluid Embolism
por: Long, Miranda, et al.
Publicado: (2022)